APRINOIA Therapeutics (APRI) – Analyst Comments
-
Apricus Bio's (APRI) ALD403 Data is Positive, But May Not Compare to Prior Teva Data - Evercore
-
Roth Capital Cuts Price Target on Apricus Biosciences (APRI) to $3 Following 2Q15
-
-
-
-
Back to APRI Stock Lookup